all AI news
DeepCRE: Revolutionizing Drug R&D with Cutting-Edge Computational Models
March 7, 2024, 5:42 a.m. | Yushuai Wu
cs.LG updates on arXiv.org arxiv.org
Abstract: The field of pharmaceutical development and therapeutic application both face substantial challenges. Therapeutic domain calls for more treatment alternatives while numerous promising pre-clinical drugs fail in clinical trails. One of the reasons is the inadequacy of Cross-drug Response Evaluation (CRE) during the late stage of drug development. Although in-silico CRE models offer a solution to this problem, existing methodologies are either limited to early development stages or lack the capacity for a comprehensive CRE analysis. …
abstract application arxiv challenges clinical computational cs.ai cs.lg development domain drug development drugs edge evaluation face pharmaceutical q-bio.qm r&d stage treatment type
More from arxiv.org / cs.LG updates on arXiv.org
Jobs in AI, ML, Big Data
Data Architect
@ University of Texas at Austin | Austin, TX
Data ETL Engineer
@ University of Texas at Austin | Austin, TX
Lead GNSS Data Scientist
@ Lurra Systems | Melbourne
Senior Machine Learning Engineer (MLOps)
@ Promaton | Remote, Europe
Data Scientist
@ Publicis Groupe | New York City, United States
Bigdata Cloud Developer - Spark - Assistant Manager
@ State Street | Hyderabad, India